These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
387 related articles for article (PubMed ID: 33171227)
21. Lipophilic methylene blue analogues enhance mitochondrial function and increase frataxin levels in a cellular model of Friedreich's ataxia. Khdour OM; Bandyopadhyay I; Chowdhury SR; Visavadiya NP; Hecht SM Bioorg Med Chem; 2018 Jul; 26(12):3359-3369. PubMed ID: 29773347 [TBL] [Abstract][Full Text] [Related]
22. Targeting lipid peroxidation and mitochondrial imbalance in Friedreich's ataxia. Abeti R; Uzun E; Renganathan I; Honda T; Pook MA; Giunti P Pharmacol Res; 2015 Sep; 99():344-50. PubMed ID: 26141703 [TBL] [Abstract][Full Text] [Related]
23. Mouse models for Friedreich ataxia exhibit cardiomyopathy, sensory nerve defect and Fe-S enzyme deficiency followed by intramitochondrial iron deposits. Puccio H; Simon D; Cossée M; Criqui-Filipe P; Tiziano F; Melki J; Hindelang C; Matyas R; Rustin P; Koenig M Nat Genet; 2001 Feb; 27(2):181-6. PubMed ID: 11175786 [TBL] [Abstract][Full Text] [Related]
25. PGC-1alpha down-regulation affects the antioxidant response in Friedreich's ataxia. Marmolino D; Manto M; Acquaviva F; Vergara P; Ravella A; Monticelli A; Pandolfo M PLoS One; 2010 Apr; 5(4):e10025. PubMed ID: 20383327 [TBL] [Abstract][Full Text] [Related]
26. Neurons and cardiomyocytes derived from induced pluripotent stem cells as a model for mitochondrial defects in Friedreich's ataxia. Hick A; Wattenhofer-Donzé M; Chintawar S; Tropel P; Simard JP; Vaucamps N; Gall D; Lambot L; André C; Reutenauer L; Rai M; Teletin M; Messaddeq N; Schiffmann SN; Viville S; Pearson CE; Pandolfo M; Puccio H Dis Model Mech; 2013 May; 6(3):608-21. PubMed ID: 23136396 [TBL] [Abstract][Full Text] [Related]
27. Interplay of FXN expression and lipolysis in white adipocytes plays a critical role in insulin sensitivity in Friedreich's ataxia mouse model. Wu L; Huang F; Yang L; Yang L; Sun Z; Zhang J; Xia S; Zhao H; Ding Y; Bian D; Li K Sci Rep; 2024 Aug; 14(1):19876. PubMed ID: 39191875 [TBL] [Abstract][Full Text] [Related]
28. Transcriptional profiling of isogenic Friedreich ataxia neurons and effect of an HDAC inhibitor on disease signatures. Lai JI; Nachun D; Petrosyan L; Throesch B; Campau E; Gao F; Baldwin KK; Coppola G; Gottesfeld JM; Soragni E J Biol Chem; 2019 Feb; 294(6):1846-1859. PubMed ID: 30552117 [TBL] [Abstract][Full Text] [Related]
36. Friedreich ataxia: an update on animal models, frataxin function and therapies. González-Cabo P; Llorens JV; Palau F; Moltó MD Adv Exp Med Biol; 2009; 652():247-61. PubMed ID: 20225031 [TBL] [Abstract][Full Text] [Related]
37. Generation and characterisation of Friedreich ataxia YG8R mouse fibroblast and neural stem cell models. Sandi C; Sandi M; Jassal H; Ezzatizadeh V; Anjomani-Virmouni S; Al-Mahdawi S; Pook MA PLoS One; 2014; 9(2):e89488. PubMed ID: 24586819 [TBL] [Abstract][Full Text] [Related]
38. Progressive mitochondrial protein lysine acetylation and heart failure in a model of Friedreich's ataxia cardiomyopathy. Stram AR; Wagner GR; Fogler BD; Pride PM; Hirschey MD; Payne RM PLoS One; 2017; 12(5):e0178354. PubMed ID: 28542596 [TBL] [Abstract][Full Text] [Related]
39. Correlation between frataxin expression and contractility revealed by in vitro Friedreich's ataxia cardiac tissue models engineered from human pluripotent stem cells. Wong AO; Wong G; Shen M; Chow MZ; Tse WW; Gurung B; Mak SY; Lieu DK; Costa KD; Chan CW; Martelli A; Nabhan JF; Li RA Stem Cell Res Ther; 2019 Jul; 10(1):203. PubMed ID: 31286988 [TBL] [Abstract][Full Text] [Related]
40. Neurodegeneration in Friedreich's ataxia: from defective frataxin to oxidative stress. Gomes CM; Santos R Oxid Med Cell Longev; 2013; 2013():487534. PubMed ID: 23936609 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]